Body Map

Peptides, mapped to the body.

Pick a part of the body to see the peptides people use for it. Each card puts the research grade next to what first-hand posters on Reddit and X said, with the counts behind every number.

Data: 1,196 first-hand posts about 15 peptides, Jun 7, 2026 – Oct 12, 2026Updated Oct 27, 2026How we countMedical review: pending

  • FDA-approved
  • Not FDA-approved
  • Cosmetic
  • Side effect posters mention

Tap a dot to see the peptides for that body area.

Which peptides act on the gut and body weight?

GLP-1 drugs act on appetite and the gut. Some repair peptides are studied for the gut lining. Weight Loss guide →

Tirzepatide

FDA-approved

Metabolic · studied for Obesity / type 2 diabetes

Research says

S research grade · Tier 1 (Human RCT)

GIP/GLP-1 dual agonist; ~21% weight loss in SURMOUNT-1, approved.

Graded Jun 7, 2026.

Posters say

202 of 320 first-hand posters who gave a verdict on Tirzepatide for fat loss said it worked (63%).

100 said results were mixed and 18 said it did not work.

Self-reported on Reddit and X, posts from Jun 8, 2026 – Oct 12, 2026. Unverified — not a success rate. How we count
  • Side effects mentioned: nausea in 54 of 514 first-hand posts about Tirzepatide; diarrhoea in 35 of 514 first-hand posts about Tirzepatide; fatigue in 31 of 514 first-hand posts about Tirzepatide. These count mentions, not how often it happens.
  • Stopping: 69 of 514 first-hand posts about Tirzepatide mention stopping it.
  • Time on it: a median of 10 weeks, in the 289 posts that said how long.

Semaglutide

FDA-approved

Metabolic · studied for Obesity / type 2 diabetes

Research says

S research grade · Tier 1 (Human RCT)

GLP-1 agonist; large STEP + cardiovascular trials, approved.

Graded Jun 7, 2026.

Posters say

42 of 96 first-hand posters who gave a verdict on Semaglutide for fat loss said it worked (44%).

33 said results were mixed and 21 said it did not work.

Self-reported on Reddit and X, posts from Jun 8, 2026 – Oct 10, 2026. Unverified — not a success rate. How we count
  • Side effects mentioned: nausea in 27 of 151 first-hand posts about Semaglutide; fatigue in 14 of 151 first-hand posts about Semaglutide; vomiting in 10 of 151 first-hand posts about Semaglutide. These count mentions, not how often it happens.
  • Stopping: 65 of 151 first-hand posts about Semaglutide mention stopping it.
  • Time on it: a median of 9.5 weeks, in the 68 posts that said how long.

Retatrutide

Not FDA-approved

Metabolic · studied for Obesity

Research says

B research grade · Tier 3 (Animal)

Biggest phase-2 weight loss yet (~24%); investigational, phase-3 ongoing.

Graded Jun 7, 2026.

Posters say

34 of 51 first-hand posters who gave a verdict on Retatrutide for fat loss said it worked (67%).

14 said results were mixed and 3 said it did not work.

Self-reported on Reddit and X, posts from Jun 7, 2026 – Oct 11, 2026. Unverified — not a success rate. How we count
  • Side effects mentioned: fatigue in 7 of 90 first-hand posts about Retatrutide. These count mentions, not how often it happens.
  • Stopping: 15 of 90 first-hand posts about Retatrutide mention stopping it.
  • Time on it: a median of 7 weeks, in the 45 posts that said how long.

BPC-157

Not FDA-approvedBanned in sport (WADA)

Recovery · studied for Gut / tendon repair

Research says

B research grade · Tier 3 (Animal)

Extensive replicated animal data; human trials thin.

Graded Jun 7, 2026.

Posters say

20 of 26 first-hand posters who gave a verdict on BPC-157 for healing an injury or the gut said it worked (77%).

3 said results were mixed and 3 said it did not work.

Self-reported on Reddit and X, posts from Jun 9, 2026 – Oct 9, 2026. Unverified — not a success rate. How we count
  • Side effects mentioned: injection-site reaction in 5 of 46 first-hand posts about BPC-157. These count mentions, not how often it happens.
  • Stopping: 6 of 46 first-hand posts about BPC-157 mention stopping it.
  • Time on it: a median of 8 weeks, in the 14 posts that said how long.

KPV

Not FDA-approved

Inflammation · studied for Anti-inflammatory (IBD/MCAS)

Research says

C research grade · Tier 4 (In vitro / mechanistic)

Promising preclinical; little human outcome data.

Graded Jun 7, 2026.

Posters say

Fewer than 10 first-hand posters gave a verdict on KPV for healing an injury or the gut, so we show no result. 44 first-hand posts mention using it.

  • Stopping: 5 of 44 first-hand posts about KPV mention stopping it.
  • Time on it: a median of 4 weeks, in the 13 posts that said how long.

How to read this map

Research says is our grade of the published evidence, S to D. It maps to our evidence tiers: S is Tier 1 (human randomised trials), B is Tier 3 (mostly animal studies).

Posters say counts first-hand Reddit and X posts that gave a verdict. People who post are not a random sample, and nothing is verified. We show a result only when at least 10 posters gave a verdict for that goal. Side effects and stopping count how many posts mention them — not how often they happen.

This page is not medical advice. Talk to a physician before you start, stop or change any treatment. Full method.